Analysis of CGGA data showed that C5aR1 expression increased with increasing glioma grade and that C5aR1 overexpression was associated with poor prognosis in patients with glioma, as indicated by the low survival rate of patients with high C5aR1 expression (Fig. 1A–C). This evidence concerns the gene C5AR1 and glioma.